freephone 0800 862 0373
Sign in to view your quotes
Email address:
Password or PIN:

Forgotten your password? Reset it here.

Breast cancer drugs Herceptin and Tyverb turned down for use on NHS again by NICE

Published on 14/02/2012

The National Institute for Health and Clinical Excellence has rejected breast cancer drugs Herceptin and Tyverb in a particular combination with hormone therapy for use on the NHS.

GlaskoSmithKline’s Tyverb and Roche’s Herceptin are licensed for use alongside hormone therapy in postmenopausal breast cancer patients whose breast cancer has spread.

Tyverb and Herceptin can reduce the growth and further spread of metastatic breast cancer tumours when taken alongside hormone therapy.

The acquisition cost for a lifetime of treatment of Tyverb plus hormone therapy is £28,212, and for Herceptin plus hormone therapy around £26,000.

However, the incremental cost per quality-adjusted life year has been calculated at more than £74,000 for Tyverb, and £51,000 for Herceptin compared with hormone therapy alone. QALY is a measure of disease burden, including both the quality and the quantity of life lived.

The normal threshold set by NICE for use on the NHS is £20,000-£30,000.

In new draft guidance published this morning NICE said that overall survival benefit from the drug appears to be small or undefined.

NICE chief executive Sir Andrew Dillon said: “independent economic analyses indicate that both treatment combinations do not appear to be cost effective for the NHS because they have uncertain clinical benefits for the price that the NHS is being asked to pay."

Herceptin is already recommended for use on the NHS in several indications, including for women who have early-stage HER2-positive breast cancer after they have had surgery and chemotherapy, as well as for HER2-positive metastatic gastric cancer.

Compare health insurance quotes from all leading insurers with ActiveQuote online now to make sure you are covered for licensed cancer drugs when you need it most.

© ActiveQuote Ltd. 2012

Categories:  NHS and Hospitals
Breast cancer drugs Herceptin and Tyverb turned down for use on NHS again by NICEThe National Institute for Health and Clinical Excellence has rejected breast cancer drugs Herceptin and Tyverb in a particular combinatio    tweet it on twittershare with your friends on Facebookshare with your friends on MySpaceBlog it on your LinkedIn profile

No.1 health insurance broker as rated by customers

A great service from the initial call, to finalising the agreement. I would highly recommend to my family and friends.

Review centre member

Proactive, efficient, and offered me insurance I need. I would say half price I would end up paying if I did it by myself. Many thanks.

Review centre member

Excellent service. Explained everything in detail and really helped to find the right insurance best suited to my needs - which wasn't necessarily the most expensive. 

Review centre member

Good value and the advisor was very helpful and recommended the best policy for my grandson. I would definitely use this service again and recommend to others.

Review centre member

We were contacted in good time to make a knowledgable choice. We were given plenty of options with lots of information to enable us to make the right choice.

Review centre member

The service I received was excellent, the staff member was very efficient and knowledgable. She went out of her way to get the best policy for me.

Review centre member

Great service. I really appreciated the help provided by Active Quote to arrange health insurance. The agent was very informative and proactive. Many thanks!

Review centre member

I received excellent care and attention from the first phone call till the last. Friendly, efficient and patient.

Review centre member

Staff are very helpful, friendly and polite. They call back when they say they will and keep you up to date with progress. Pleasure to deal with.

Review centre member

Very polite and friendly, and gave detailed explanations of all aspects of the cover. Reassuring to know that if you do have a problem there is someone you can contact.

Review centre member
This site is operated by Insurance Broker ActiveQuote Ltd registered in England & Wales company number 6765845.
Authorised and Regulated by the Financial Conduct Authority (FCA). Firm reference number 501109 as detailed on the Financial Services Register. Please read our Key Facts document.
For information about your rights as a consumer visit Citizens Advice.

Our insurance comparison service is free and easy for you to use, but you are responsible for making sure all your information is entered correctly, and for choosing your insurer.

This site uses cookies in order to work correctly - these are not harmful and do not contain personal information. By using this site you consent to this. I understand  Tell me more

please wait ...